S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis

S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis

Bibliographic Details
Main Authors:	V Oke, E Svenungsson, I Gunnarsson, B SUNDELIN, A Zickert, A Larsson, F Faustini, A Häyry
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
by: Anders Larsson, et al.
Published: (2022-07-01)

P10 IL-16 expression in kidney biopsies from patients with SLE- and antiphosholipid syndrome- associated renal thrombotic microangiopathy and renal IgA vasculitis
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

16 Management of lupus nephritis
by: YK Onno Teng
Published: (2023-09-01)

O12 Immune complexes containing anti-dsDNA in patients with systemic lupus erythematosus with renal involvement – Association with renal activity and response to treatment
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Urinary Sediments as Predictors of the Histopathology of Lupus Nephritis
by: Sally M Gamaleldin, et al.
Published: (2022-01-01)

A Preliminary Predictive Model for Proliferative Lupus Nephritis in Juvenile Systemic Lupus Erythematosus
by: Sern Chin Lim, et al.
Published: (2023-02-01)

Long-term renal outcomes of patients with non-proliferative lupus nephritis
by: Eun-Song Kang, et al.
Published: (2023-09-01)

O34 Plasma thrombospondin-1 levels are associated with arterial and venous thrombotic events in systemic lupus erythematosus
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Urinary biomarkers associated with podocyte injury in lupus nephritis
by: Zhiying Guo, et al.
Published: (2024-01-01)

Stability of novel urinary biomarkers used for lupus nephritis
by: Ellen M. Cody, et al.
Published: (2022-07-01)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
by: Miguel Marín-Rosales, et al.
Published: (2022-12-01)

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
by: Trivedi Hargovind L, et al.
Published: (2008-02-01)

Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative lupus nephritis
by: Yoshiya Tanaka, et al.
Published: (2023-11-01)

LP-097 Degranulating PR3+ myeloid cells characterize proliferative lupus nephritis
by: Michelle Petri, et al.
Published: (2023-07-01)

O44 Long-term outcomes of chronic kidney disease patients with lupus nephritis: a nationwide cohort study
by: Iva Gunnarsson, et al.
Published: (2024-03-01)

Management of Lupus Nephritis
by: Farah Tamirou, et al.
Published: (2021-02-01)

Elevated serum levels of human epididymis protein 4 in adult patients with proliferative lupus nephritis
by: Liubing Li, et al.
Published: (2023-05-01)

Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis
by: Cheuk-Chun Szeto, et al.
Published: (2023-07-01)

Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression
by: Dawn J. Caster, et al.
Published: (2021-02-01)

Assessment of the Role of Urinary Heparanase in Lupus Nephritis Patients and Its Correlation with Disease Activity
by: Mustafa A Abou-Alfa, et al.
Published: (2022-01-01)

Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013-01-01)

Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010)

Lupus Nephritis and Dysbiosis
by: Marta Monticolo, et al.
Published: (2023-04-01)

Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)

Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis
by: Shanshan Chen, et al.
Published: (2023-02-01)

P130 Patients’ thoughts of triggers for lupus onset and flares
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Serum S100P and C4d proteins as markers for active proliferative lupus nephritis in Egyptian patients with systemic lupus erythematosus
by: Mahmoud M. Elnokeety, et al.
Published: (2023-09-01)

O39 Immune deposit resorption in per-protocol repeat kidney biopsy performed in patients with proliferative lupus nephritis
by: Farah Tamirou, et al.
Published: (2024-03-01)

Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation
by: Leran Chen, et al.
Published: (2023-12-01)

Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis
by: Shogo Ijima, et al.
Published: (2022-11-01)

Urinary Modified C-Reactive Protein is Closely Associated with Tubulointerstitial Lesions in Lupus Nephritis
by: Mo Yuan, et al.
Published: (2023-01-01)

An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis
by: Cristina Solé, et al.
Published: (2019-07-01)

The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis
by: Eloi Garcia-Vives, et al.
Published: (2020-02-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis
by: Dominic Sinibaldi, et al.
Published: (2023-01-01)

Renal Fibrosis in Lupus Nephritis
by: Savino Sciascia, et al.
Published: (2022-11-01)

17 Management of lupus nephritis
by: Luis Quintana
Published: (2023-09-01)

Lupus nephritis in the XXI century
by: Irina N. Bobkova, et al.
Published: (2022-08-01)

The Clinicopathological Study of Lupus Nephritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01)

14 Management of lupus nephritis
by: Gabriella Moroni
Published: (2022-04-01)